Cargando…
Clinical Theragnostic Potential of Diverse miRNA Expressions in Prostate Cancer: A Systematic Review and Meta-Analysis
Background: Prostate cancer (PrC) is the second-most frequent cancer in men, its incidence is emerging globally and is the fifth leading cause of death worldwide. While diagnosis and prognosis of PrC have been studied well, the associated therapeutic biomarkers have not yet been investigated compreh...
Autores principales: | Jayaraj, Rama, Raymond, Greg, Krishnan, Sunil, Tzou, Katherine S., Baxi, Siddhartha, Ram, M. Ravishankar, Govind, Suresh Kumar, Chandramoorthy, Harish C., Abu-Khzam, Faisal N., Shaw, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281275/ https://www.ncbi.nlm.nih.gov/pubmed/32397507 http://dx.doi.org/10.3390/cancers12051199 |
Ejemplares similares
-
Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis
por: Shaw, Peter, et al.
Publicado: (2022) -
Clinical Theragnostic Relationship between Chemotherapeutic Resistance, and Sensitivity and miRNA Expressions in Head and Neck Cancers: A Systematic Review and Meta-Analysis Protocol
por: Shaw, Peter, et al.
Publicado: (2021) -
Mapping Research on miRNAs in Cancer: A Global Data Analysis and Bibliometric Profiling Analysis
por: Shaw, Peter, et al.
Publicado: (2022) -
A Clinical Update on the Prognostic Effect of microRNA Biomarkers for Survival Outcome in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
por: Shaw, Peter, et al.
Publicado: (2021) -
A Clinical Investigation on the Theragnostic Effect of MicroRNA Biomarkers for Survival Outcome in Cervical Cancer: A PRISMA-P Compliant Protocol for Systematic Review and Comprehensive Meta-Analysis
por: Shaw, Peter, et al.
Publicado: (2022)